Patient Pathfinder: Clinical Trials
Clinical Trials for Acute Myeloid Leukemia
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 386 active Acute Myeloid Leukemia trials
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
Study Type: Interventional Phase 1
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Study Type: Observational
A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia
Study Type: Interventional Phase 2
A Phase 1, Study of BMF-500 in Adults With Acute Leukemia
Study Type: Interventional Phase 1
A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies (BEXMAB)
Study Type: Interventional Phase 1
A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia
Study Type: Interventional Phase 1
Venetoclax to Augment Epigenetic Modification and Chemotherapy
Study Type: Interventional Phase 1
A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)
Study Type: Interventional Phase 1
There are 386 active Acute Myeloid Leukemia trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now